| | | | | Where your investment dreams come to life |
| |
|
| They're calling it a "biological missile."
Stanford University dubbed it a "cancer seeking... smart bomb."
But what we're talking about is the single most powerful weapon created in the battle against cancer.
Once it enters the bloodstream, this "Bio-missile" systematically hunts down, and eliminates, every cancer cell in your body...
...While leaving every normal, healthy cell in your body completely intact.
It's one reason a team of researchers from Harvard Medical went so far as to dub this 'Smart Chemo.'
Right now, it has already saved the lives of 27,100 women with one form of breast cancer... and is being calibrated to attack the remaining 200 forms of the disease.
Even the FDA is on the bandwagon - they just provided accelerated approval for a lymphoma treatment.
We're talking about potentially wiping the sixth most common type of cancer in the world... right off the map.
And this $4 micro-cap company just won the FDA approval.
Morgan Stanley is expecting it to "transform cancer care."
Pfizer just made a $43 billion investment - one of the biggest of its 175-year existence.
And again - one tiny biotech is leading the charge.
And I'm sharing all the details... including the breakdown of what exactly the "Bio-Missile" is and how it works...
At this link right here>>>
Sincerely,
Samantha Tino, Editor
Behind the Markets |
|
|
| | At Star Investing Ship, we keep an eye out for favorable opportunities we believe will interest our readers. The following is one such message from one of our colleagues that we think you'll appreciate. |
|
| Email sent by FIT, LLC, owner and operator of Star Investing Ship (SIS).
This offer is brought to you by Star Investing Ship. 221 W 9th St # Wilmington, DE 19801. If you would like to unsubscribe from receiving offers brought to you by Star Investing Ship click here.
Keep up to date with the world of investing and finance by whitelisting us.
|
| | | Copyright 2024 StarInvestingShip.com. All Rights Reserved.
| | |
|
|
|
|
|
|
|
|
